Levonorgestrel
- Product NDC
- 73302-911
- 11-digit product format
- 733020911
- Labeler code
- 73302
- Product ID
- 73302-911_054f9706-94d2-4ea3-8e32-7185457f5c63
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levonorgestrel
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- HRA Pharma America, Inc.
- Application
- ANDA204044
- Marketing category
- ANDA
- Marketing start
- 2020-11-01
- Marketing end
- 0000-00-00
- Substance
- LEVONORGESTREL
- Active strength
- 2 mg/1
- Pharmacologic classes
- Inhibit Ovum Fertilization [PE],Progesterone Congeners [CS],Progesterone Congeners [CS],Progestin [EPC],Progestin-containing Intrauterine Device [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73302-911-01 | 73302091101 | 1 TABLET in 1 CARTON (73302-911-01) | 1 tablet | 2020-11-01 | 0000-00-00 | No | No | Current |